European Union approves COVID-19 vaccine developed by Pfizer-BioNTech
On December 21, 2020, the European Medicines Agency (EMA) gave conditional marketing authorization for the COVID-19 vaccine developed by Pfizer-BioNTech. Italy, being a member of the European Union, was part of the coordinated effort to administer vaccinations across EU nations. This marked a significant step towards combating the COVID-19 pandemic, which has severely affected Italy, especially in its early stages.